The U.S. needs to support American-made medicines
CPA’s Take: CivicaRX CEO Martin VanTrieste explains why it is essential, and achievable to reshore pharmaceutical production to the US. Two years ago, a group
CPA’s Take: CivicaRX CEO Martin VanTrieste explains why it is essential, and achievable to reshore pharmaceutical production to the US. Two years ago, a group
Each year, the Office of the U.S. Trade Representative (USTR) produces a report on China’s compliance with its World Trade Organization (WTO) commitments. Ahead of
CPA’s Take: The WTO just pounded more nails into its own coffin. CPA is quoted in this article. U.S. disputes finding, has long called World
By Kenneth Rapoza, CPA Industry Analyst The World Trade Organization has ruled that over $230 billion worth of the Trump Administration’s “fair trade” tariffs, known
CPA’s Take: Good to see POTUS start to talk about decoupling from China. Ending federal contracts with companies who offshore is an important idea. President
CPA’s Take: The first two people mentioned as Biden trade advisors, Jennifer Hillman and Miriam Sapiro, are pro-globalists that don’t care where things are made. WASHINGTON/WILMINGTON,
CPA’s Take: This is excellent. Finally, import competition is being accepted in agriculture as harmful to domestic producers. Washington, DC — The Office of the U.S.
CPA’s Take: CPA supports efforts to remove Chinese stocks from the US stock market because they do not let us access their audited financial records. It
CPA’s Take: The battle within the Biden campaign on trade between the Wall Street globalists and the fair traders is real. The former vice president
CPA’s Take: Very bad! The IMF has failed to stop currency manipulation. The US has acted with a modest regulation that defines when we can